Han, S.Y.; Lu, Q.; Lee, K.; Choi, Y.H.
LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats. Pharmaceutics 2019, 11, 135.
https://doi.org/10.3390/pharmaceutics11030135
AMA Style
Han SY, Lu Q, Lee K, Choi YH.
LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats. Pharmaceutics. 2019; 11(3):135.
https://doi.org/10.3390/pharmaceutics11030135
Chicago/Turabian Style
Han, Seung Yon, Qili Lu, Kyeong Lee, and Young Hee Choi.
2019. "LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats" Pharmaceutics 11, no. 3: 135.
https://doi.org/10.3390/pharmaceutics11030135
APA Style
Han, S. Y., Lu, Q., Lee, K., & Choi, Y. H.
(2019). LC478, a Novel Di-Substituted Adamantyl Derivative, Enhances the Oral Bioavailability of Docetaxel in Rats. Pharmaceutics, 11(3), 135.
https://doi.org/10.3390/pharmaceutics11030135